EMD Serono Offers a New Patient Assistance Program for Rebif®

July 2, 2007

As a way to expand access to therapy, a new patient assistance program titled MS LifeLines® Access Made Simple was launched on July 2, 2007 by EMD Serono. According to EMD Serono, "The program provides simplified and affordable access to therapy for people with relapsing forms of multiple sclerosis (MS) who have either been newly prescribed Rebif (interferon beta-1a) by their physician or who have restarted Rebif therapy after having discontinued for more than 90 days." All eligible patients will receive a supply of Rebif up to one year, regardless of income, with no more than a $50 co-payment. After one year, patients who are still unable to obtain full insurance coverage for Rebif can apply to the MS LifeLines Patient Assistance Program (PAP), which provides financial support to people who cannot otherwise afford therapy.

There is no new enrollment process for the MS LifeLines Access Made Simple program. Eligible patients can participate in the program through enrollment in MS LifeLines support services. If you have any further questions, please contact MS LifeLines at (877) 447-3243.